The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows ...

China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

Chinese firms can accelerate clinical trials and bring their drugs to market faster with more supportive policies, ...

Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

Mushrooms found in the forests of Bankura and Birbhum in West Bengal could become a game-changer in cancer treatment.

Limited or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' ...

Emily Yu, a longtime Beijing-based lingerie designer, has devoted some five years to developing bras and prostheses for women ...